Laidlaw Reiterates Buy Rating on Viking Therapeutic (VKTX)

February 12, 2026 2:45 AM EST Send to a Friend
Laidlaw analyst Yale Jen reiterated a Buy rating and $110.00 price target on Viking Therapeutic (NASDAQ: VKTX)The analyst comments: "VKTX ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login